1995
DOI: 10.1001/archpedi.1995.02170180089017
|View full text |Cite
|
Sign up to set email alerts
|

Immunization Coverage Among Infants Enrolled in the Tennessee Medicaid Program

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

1996
1996
2020
2020

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 18 publications
(6 citation statements)
references
References 17 publications
0
6
0
Order By: Relevance
“…This finding has been demonstrated in the United States, but to our knowledge, has not been previously documented in resource-constrained settings. [34][35][36][37] In this setting, delayed pentavalent1 vaccine could be used as an early warning system to alert practitioners that this child is at higher risk for drop-out of the EPI schedule.…”
Section: Discussionmentioning
confidence: 99%
“…This finding has been demonstrated in the United States, but to our knowledge, has not been previously documented in resource-constrained settings. [34][35][36][37] In this setting, delayed pentavalent1 vaccine could be used as an early warning system to alert practitioners that this child is at higher risk for drop-out of the EPI schedule.…”
Section: Discussionmentioning
confidence: 99%
“…AD is pathologically characterized by the accumulation of amyloid-beta (Aβ) plaques, tau neurofibrillary tangles (NFTs), synaptic and neuronal loss, glial activation, and neuroinflammation [6][7][8][9][10][11]. Aβ plaques and NFTs induce an immune response associated with astroglia and microglia activation and increased inflammatory mediators, tumor necrosis factor α [12], S100, interleukin 1 [13,14], such as triggering receptor expressed on myeloid cells 2 (TREM2) [15,16], and complement activation (C1q to C5b-9) [17] in AD [18][19][20]. Recently, the chitinase family of inflammatory proteins, particularly chitinase 3-like 1 (CHI3L1, YKL-40, or HC gp-39), chitinase 3-like 2 (CHI3L2 or YKL- 39), and pentraxin II (NPTX2 or Narp), a member of the pentraxin family, has been associated with AD pathogenesis [21,22].…”
Section: Introductionmentioning
confidence: 99%
“…40 Previous estimates of immunization rates have ranged widely (between 11% and 82%) depending on the populations and data collection methods used. [41][42][43][44][45] Our finding that CCHP-enrolled children had comparable documented immunization rates to children with other insurance before they enrolled in the program differs from previous reports showing lower immunization rates in uninsured children than in children with insurance. 46,47 The rates in our study may have been similar because of prior MK enrollment in some children or, in younger children, beneficial effects of the federal Vaccines For Children program that made free vaccine available to the uninsured in Colorado's private sector after 1995.…”
Section: Discussionmentioning
confidence: 86%